Rare diseases
Investigational molecules
Locations
Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
AustriaStudy on L19TNF and Doxorubicin for Patients with Advanced or Metastatic Soft Tissue Sarcoma
FranceStudy on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
BelgiumStudy of alpelisib and olaparib combination compared to chemotherapy in patients with platinum-resistant high-grade serous ovarian cancer without BRCA mutation
FinlandStudy of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer
IrelandStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
AustriaStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
AustriaStudy of Brentuximab Vedotin, Doxorubicin Hydrochloride, and Dacarbazine for Patients with Untreated Classical Hodgkin Lymphoma
CzechiaStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
AustriaStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
